Go overweight on pharma; buy midcap IT basket, tier II PSU banks now: Dipan Mehta

October 24, 2024

Pharma stocks are currently seen as a strong investment due to robust earnings potential. Midcap IT stocks are outperforming their largecap counterparts. L&T’s entry into the power equipment sector might increase competition. FMCG sector growth appears slow, but niche categories may offer opportunities. Tier II PSU banks are also showing potential despite higher valuations.

More To Explore

D-Mart and Trent to outperform amidst India’s changing consumption landscape: Jignanshu Gor

Jignanshu Gor, from Bernstein India, shares insights on retail and restaurant stocks, highlighting an outperform rating on D-Mart, Trent, Jubilant, and Devyani. He explains the

February 12, 2025

Ashok Leyland Q3 Results: Cons PAT surges 36% YoY to Rs 762 crore, revenue rises 8%

The Q3FY25 revenue from operations stood at Rs 11,995 crore, an increase of over 8% from Rs 11,066 crore reported in the corresponding quarter of

February 12, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003